Burning Rock Publishes 2023 Annual Report on Form 20-F
April 29, 2024 03:30 ET
|
Burning Rock Biotech Limited
Burning Rock Publishes 2023 Annual Report on Form 20-F
Burning Rock Announces ADS Ratio Change
April 26, 2024 01:59 ET
|
Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 17:16 ET
|
Burning Rock Biotech Limited
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
Burning Rock Announces Receipt of Notification from NASDAQ
January 04, 2024 01:03 ET
|
Burning Rock Biotech Limited
Burning Rock Announces Receipt of Notification from NASDAQ
Burning Rock Announces Results of 2023 Annual General Meeting
December 19, 2023 21:35 ET
|
Burning Rock Biotech Limited
Burning Rock Announces Results of 2023 Annual General Meeting
Burning Rock Reports Third Quarter 2023 Financial Results
November 30, 2023 01:25 ET
|
Burning Rock Biotech Limited
Burning Rock Reports Third Quarter 2023 Financial Results
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
November 22, 2023 02:04 ET
|
Burning Rock Biotech Limited
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
November 20, 2023 20:55 ET
|
Burning Rock Biotech Limited
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
October 30, 2023 03:20 ET
|
Burning Rock Biotech Limited
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
October 15, 2023 19:18 ET
|
Burning Rock Biotech Limited
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test